Tag Archives: Partner

Business Wire: Roche Announces Partner Ipsens Taspoglutide meet its primary endpoint in a phase III of clinical importance. . .

BUSINESS WIRE: Ipsens Partner Roche Announces That Taspoglutide Meets Its Primary Endpoint in a Key Phase III Clinical … MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH. Read more on vwd.de

Posted in Neuropathy Product | Tagged , , , , , , , , , , , , | Leave a comment